BACKGROUND: Animal studies with systemic nitric oxide synthase (NOS) inhibition and renal ablation, suggest that NO deficiency is both a cause and a consequence of chronic renal disease (CRD). METHODS: This study examined a glomerulonephritis (GN) model of CRD to determine if NO is deficient. In addition to measuring indices of renal function (proteinuria, creatinine clearance, structural damage), indices of total and renal nitric oxide production also were assessed (total NO(X) excretion, renal NOS activity, renal NOS protein abundance, plasma levels of NOS substrate and endogenous inhibitor). RESULTS: Rats developed increasing proteinuria 12 to 20 weeks after induction of GN (with anti-glomerular basement membrane, GBM, antibody) and at 20 weeks exhibited reduced creatinine clearances and increased glomerulosclerosis relative to age-matched controls. Total NO(X) excretion was reduced and the renal cortical NOS activity and neuronal NOS (nNOS) abundance was decreased relative to controls. There was no impact on renal or aortic endothelial NOS expression or cerebellar nNOS. The plasma l-arginine (Arg) concentration was well maintained but plasma asymmetric dimethylarginine (ADMA) concentration increased in GN versus control animals. CONCLUSIONS: Total and renal NOS activity is reduced in the GN model of CRD due to increased circulating endogenous NOS inhibitors and decreased renal nNOS abundance.
BACKGROUND: Animal studies with systemic nitric oxide synthase (NOS) inhibition and renal ablation, suggest that NO deficiency is both a cause and a consequence of chronic renal disease (CRD). METHODS: This study examined a glomerulonephritis (GN) model of CRD to determine if NO is deficient. In addition to measuring indices of renal function (proteinuria, creatinine clearance, structural damage), indices of total and renal nitric oxide production also were assessed (total NO(X) excretion, renal NOS activity, renal NOS protein abundance, plasma levels of NOS substrate and endogenous inhibitor). RESULTS:Rats developed increasing proteinuria 12 to 20 weeks after induction of GN (with anti-glomerular basement membrane, GBM, antibody) and at 20 weeks exhibited reduced creatinine clearances and increased glomerulosclerosis relative to age-matched controls. Total NO(X) excretion was reduced and the renal cortical NOS activity and neuronal NOS (nNOS) abundance was decreased relative to controls. There was no impact on renal or aortic endothelial NOS expression or cerebellar nNOS. The plasma l-arginine (Arg) concentration was well maintained but plasma asymmetric dimethylarginine (ADMA) concentration increased in GN versus control animals. CONCLUSIONS: Total and renal NOS activity is reduced in the GN model of CRD due to increased circulating endogenous NOS inhibitors and decreased renal nNOS abundance.
Authors: A Furusu; M Miyazaki; K Abe; S Tsukasaki; K Shioshita; O Sasaki; K Miyazaki; Y Ozono; T Koji; T Harada; H Sakai; S Kohno Journal: Kidney Int Date: 1998-06 Impact factor: 10.612
Authors: S Aiello; M Noris; M Todeschini; S Zappella; C Foglieni; A Benigni; D Corna; C Zoja; D Cavallotti; G Remuzzi Journal: Kidney Int Date: 1997-07 Impact factor: 10.612
Authors: R J Schmidt; J Domico; L S Samsell; S Yokota; T S Tracy; M I Sorkin; K Engels; C Baylis Journal: Am J Kidney Dis Date: 1999-08 Impact factor: 8.860
Authors: P Heeringa; M Bijl; A de Jager-Krikken; A Zandvoort; G Dijkstra; H Moshage; J W Tervaert; A T Tiebosch; C G Kallenberg; H van Goor Journal: J Pathol Date: 2001-02 Impact factor: 7.996
Authors: Jennifer M Sasser; Natasha C Moningka; Mark W Cunningham; Byron Croker; Chris Baylis Journal: Am J Physiol Regul Integr Comp Physiol Date: 2009-12-16 Impact factor: 3.619